$PYPL

SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. Truist upgraded PayPal (PYPL) to Hold, $57 target; Leerink upgraded Edwards Lifesciences (EW) to Outperform, $101. TD Cowen upgraded Digital Realty (DLR) to Buy, $222; Morgan Stanley upgraded Progressive (PGR) to Equal Weight, $210. Several downgrades followed, including Infosys (INFY) and Albertsons (ACI). Coverage initiations included SpaceX (SPCX) and Chime (CHYM).

Original reporting
Published Jul 24, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 2:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls — source image
Decision brief

The 30-second read

$PYPLBullishMed
01

Why it matters

The actionable signal is the direction and magnitude of rating/PT changes, plus the stated catalysts (earnings softness, guidance cuts, clinical data, valuation, and demand expectations).

02

Market read

Traders can use the rating/PT changes as near-term sentiment inputs, especially where the article cites concrete negative catalysts (INFY, ACI, ROL) or specific positive readouts (STTK).

03

What to watch

For takeout speculation (PYPL) and long-dated demand timelines (DLR), the key risk is that the article provides no confirmation of execution milestones, making the catalyst quality lower than a hard guidance or contract disclosure.

Relevance 6/10Novelty 5/10Timing: today’s analyst rating and price-target changes across multiple names

Background

This is a multi-name analyst note roundup featuring rating changes, price-target revisions, and a few new coverage initiations.

Company-level read

Ticker impact

$PYPLBullishMedium confidence
Context

Truist upgraded PayPal to Hold from Sell and raised its price target to $57 from $44, citing uncertainty around the turnaround and possible Stripe/Advent takeout.

Expected impact

Near-term sentiment likely improves versus prior Sell calls, but conviction is tempered by the turnaround difficulty and takeout uncertainty.

Evidence & confidence

The article provides a concrete rating change and higher PT, but the thesis is explicitly uncertain and framed around a potential transaction rather than confirmed fundamentals.

$EWBullishMedium confidence
Context

Leerink upgraded Edwards Lifesciences to Outperform from Market Perform and lifted its price target to $101 from $87 after quarterly results.

Expected impact

Moderate upside bias as the market digests the upgrade and higher PT.

Evidence & confidence

The upgrade is directly tied to quarterly results and a higher PT, but the article does not specify the magnitude of the beat or guidance details.

$DLRBullishLow confidence
Context

TD Cowen upgraded Digital Realty to Buy from Hold, raising its price target to $222 from $192 on expectations for further large signings in late 2026 or early 2027.

Expected impact

Likely supports a re-rating if investors believe the signings timeline and demand strength are credible.

Evidence & confidence

The thesis is forward-looking and the article provides no new datapoints beyond the analyst’s demand characterization.

$PGRBullishLow confidence
Context

Morgan Stanley upgraded Progressive to Equal Weight from Underweight and increased its price target to $210 from $190, citing valuation.

Expected impact

Mild positive drift possible, especially if valuation support resonates with the market.

Evidence & confidence

The article does not add new company-specific operational metrics, only a valuation rationale.

$DOVBullishLow confidence
Context

BMO Capital upgraded Dover to Outperform from Market Perform, setting a $240 price target (down from $255) after viewing the stock’s 8% Q2 decline as overdone.

Expected impact

Could spark mean-reversion interest if investors agree the decline was excessive.

Evidence & confidence

The PT is still reduced, and the article lacks details on what changed in the quarter beyond the decline.

$CAKENeutralLow confidence
Context

Mizuho downgraded Cheesecake Factory to Neutral from Outperform and raised its price target to $85 from $75, citing valuation.

Expected impact

Potentially mixed reaction, with the downgrade capping upside despite the higher target.

Evidence & confidence

Valuation is the only stated driver, and the article does not provide new earnings or guidance specifics.

$ACIBearishMedium confidence
Context

Telsey Advisory downgraded Albertsons to Market Perform from Outperform with a $13 price target (down from $22) after a soft fiscal Q1 earnings report.

Expected impact

Near-term downside risk as the market re-prices execution and earnings trajectory.

Evidence & confidence

The downgrade is explicitly tied to a soft earnings report and a lower PT, which is a concrete decision input.

$ROLBearishMedium confidence
Context

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70 after an investor day, citing tougher near-term projections due to volatile industry demand.

Expected impact

Likely negative bias until demand volatility normalizes or management provides clearer near-term visibility.

Evidence & confidence

The article provides a clear downgrade rationale and a large PT reduction, but no new Rollins-specific operational data is included.

Market effects

Read-across is mostly within analyst coverage themes: fintech turnaround optionality (PYPL), medtech post-quarter signal (EW), data center demand visibility (DLR), and valuation-driven insurance/auto retail re-ratings (PGR, PAG).

Limited, except INFY’s guidance miss could influence broader offshore IT services sentiment.

SpaceX initiation (SPCX) and clinical/biotech initiation (STTK) may affect niche growth and risk-premium positioning, but no broad macro linkage is stated.

Counterpoint

Several PTs are raised or lowered without new company-specific datapoints in the article, so the market may discount the upgrades/downgrades as largely valuation or narrative-driven.

Key entities

  • PayPal

    Truist upgraded to Hold from Sell and raised PT to $57 from $44, citing uncertainty and potential Stripe/Advent takeout.

  • Infosys

    JPMorgan downgraded to Neutral and cut PT to $10.90 from $12.70 after a sharp Q1 miss and a second consecutive revenue guidance cut.

  • SpaceX

    HSBC initiated coverage with a Hold rating and $115 PT, flagging pricing prudence for futuristic initiatives.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.